Quantinno Capital Management LP Corcept Therapeutics Inc Transaction History

Quantinno Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $190,668 - $248,055	-8,117 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$16.78 - $27.3 $173,454 - $282,200	-10,337 Reduced 56.01%	8,117 $212,000
Q3 2020 Nov 16, 2020	SELL	$12.46 - $19.98 $172,732 - $276,982	-13,863 Reduced 42.9%	18,454 $321,000
Q2 2020 Aug 14, 2020	SELL	$11.0 - $18.26 $243,705 - $404,550	-22,155 Reduced 40.67%	32,317 $544,000
Q1 2020 May 15, 2020	BUY	$10.11 - $14.04 $550,711 - $764,786	54,472 New	54,472 $648,000
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $286,352 - $402,698	-23,744 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $247,175 - $348,087	23,744 New	23,744 $336,000
Q2 2019 Aug 14, 2019	SELL	$9.78 - $12.76 $106,377 - $138,790	-10,877 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$10.03 - $15.71 $109,096 - $170,877	10,877 New	10,877 $128,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.3B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Quantinno Capital Management LP with notifications on news.